Thermo Fisher Scientific Inc. (TMO) revealed on Friday that its Board of Directors has approved the buyback of shares worth $4 billion of its common stock. These repurchases can occur through either open market transactions or negotiated deals. This new authorization does not have an expiration date and supersedes the previous repurchase program, under which $1 billion was still available.